10-K/A: The Joint Corp. Restates 2024 Financials, Cites Material Error

The Joint Corp. announced a restatement of its 2024 annual and Q1 2025 interim financial statements due to a material error in asset valuation for discontinued operations, alongside identifying a material weakness in internal controls.

Summary

• Audited financial statements for the year ended December 31, 2024, and unaudited interim financial statements for the quarter ended March 31, 2025, have been restated.
• A material error was identified in the valuation methodology used for the fair value measurement of certain assets held for sale within discontinued operations.
• Management concluded that internal control over financial reporting was not effective as of December 31, 2024, due to a material weakness in accounting for complex areas, specifically estimated impairment related to assets held for sale.
• The company is transitioning to a pure-play franchisor business model, focusing on strategic divestitures of all company-owned or managed clinics.
• System-wide sales grew 9% to $530.3 million in 2024, up from $488 million in 2023.
• Net loss for 2024 was $5.8 million, compared to a net loss of $9.8 million in 2023 (both restated).
• Adjusted EBITDA from continuing operations decreased to $2.3 million in 2024 from $4.5 million in 2023.
• The company saw 957,000 new patients in 2024, with approximately 36% being first-time chiropractic users.

Sentiment

Score: 3

Explanation: The restatement of financial statements for a material error, coupled with the identification of a material weakness in internal controls, signals significant governance and operational deficiencies. This is the second restatement in two years, which severely erodes investor confidence and raises concerns about the reliability of financial reporting. The company continues to report net losses, and while system-wide sales show growth, the decline in Adjusted EBITDA from continuing operations and negative comparable sales for mature clinics indicate underlying profitability challenges. The ongoing labor shortages and inflationary pressures further strain the business. The strategic shift to a pure-play franchisor model, while potentially positive long-term, introduces near-term uncertainties and execution risks. Given these compounding issues, particularly the repeated financial reporting failures, a seasoned investor would likely recommend selling to mitigate further risk until the company demonstrates consistent, accurate financial reporting and sustained profitability.

Positives

• System-wide sales grew 9% to $530.3 million in 2024, up from $488 million in 2023.
• Delivered over 14.7 million patient visits in 2024, an increase from 13.6 million in 2023.
• Comparable same-store sales (Comp Sales) for 2024 increased by 4%, demonstrating business model resilience.
• Attracted 957,000 new patients in 2024, with 36% being first-time chiropractic users, indicating market expansion.
• The strategic shift to a pure-play franchisor model is progressing, with draft letters of intent received for the full portfolio of company-owned or managed clinics.
• Maintained a strong cash position with $25.1 million in cash and short-term bank deposits as of December 31, 2024.
• Management believes existing cash, anticipated cash flows from operations, and available credit will be sufficient for anticipated operating and investment needs for at least the next 12 months.

Negatives

• Restatement of previously issued audited financial statements for 2024 and unaudited interim financial statements for Q1 2025 due to a material error in asset valuation.
• Identified a material weakness in internal control over financial reporting as of December 31, 2024, specifically in accounting for complex areas like impairment of assets held for sale.
• Reported a net loss of $5.8 million in 2024, following a net loss of $9.8 million in 2023.
• Adjusted EBITDA from continuing operations decreased by 48.6% from $4.5 million in 2023 to $2.3 million in 2024.
• Income from operations decreased by $2.2 million (693.5%) to a loss of $1.9 million in 2024.
• General and administrative expenses increased by $3.9 million (14.8%) in 2024, reaching 58% of total revenues.
• Comparable sales for mature clinics (open 48 months or more) decreased by 2% in 2024.
• The nationwide labor shortage negatively impacted the ability to recruit chiropractors and other qualified personnel, leading to reduced net revenues and increased operating expenses.
• Inflation has led to increased labor costs and interest rates, which may reduce discretionary spending on services.
• Six out of 16 regional developers had not met their minimum franchise sales requirements as of December 31, 2024.
• Incurred $3.0 million in litigation expenses in 2024, including settlement costs for employment matters and a medical injury claim.

Risks

• The nationwide labor shortage has negatively impacted the ability to recruit chiropractors and other qualified personnel, which may limit growth strategy and reduce net revenues.
• Inflation has led to increased labor costs and interest rates, potentially reducing discretionary spending on services and negatively impacting business.
• New clinics may not be profitable, and historical increases in average and comparable clinic sales may not be indicative of future results.
• Failure to manage growth effectively could harm business and operating results, as existing systems may be inadequate for continued expansion.
• Opening new clinics in existing markets may negatively affect revenue at existing clinics due to cannibalization.
• Damage to reputation or brand in existing or new markets could negatively impact business, financial condition, and results of operations.
• Marketing programs may not be successful, resulting in expenses incurred without the benefit of higher revenue.
• Risks associated with leasing space subject to long-term non-cancelable leases for clinics intended to be operated, especially during refranchising efforts.
• Dependence on the success of franchisees exposes the company to risks, including loss of royalty revenue and harm to its brand.
• Franchisees are independent operators over whom the company has limited control, and their actions or failures could materially adversely affect the company's reputation and business.
• Franchise agreements may be terminated or not renewed, resulting in a reduction of royalty payments.
• Franchisees may not meet timetables for opening their clinics, which could reduce expected royalties.
• Regional developers are independent operators, and their failure to meet minimum franchise sales requirements could reduce franchise fees and delay royalties.
• The level of debt could impair financial condition and ability to operate, limiting flexibility and increasing vulnerability to adverse economic conditions.
• A material weakness in internal control over financial reporting may lead to inaccurate financial results, prevent fraud, or diminish investor confidence.
• A decline in the estimated fair value of an intangible asset or a reporting unit could result in a material impairment charge.
• A decline in current and projected cash flows in corporate clinics could result in material impairment charges on long-lived assets.
• Increased reliance on franchise revenue sources due to the refranchising strategy exposes the company to risks, including decreased total revenue and potentially prolonged general and administrative expenses.
• The company has experienced net losses in 2023 and 2024 and may not achieve or sustain profitability in the future.
• Any audit by the IRS regarding the Employee Retention Credit (ERC) could result in additional taxes or costs if the company is found ineligible for some or all of the credit.
• The chiropractic industry is highly competitive, with many well-established independent competitors and multi-unit operators.
• The company's success is dependent on chiropractors who control professional corporations (PCs), and difficulty in locating qualified replacements could impact business.
• Management services agreements with affiliated PCs could be challenged by state or chiropractors under laws regulating the practice of chiropractic.
• Uncertainties with federal regulations expanding the meaning of 'joint employer' and evolving state laws increase potential liability for employment law violations by franchisees.
• An increased regulatory focus on fair franchise practices could increase the risk of liability in disputes with franchisees and enforcement actions.
• Failure to comply with extensive federal, state, and local laws and government regulations could incur penalties or require significant operational changes.
• Chiropractors are subject to ethical guidelines and operating standards, non-compliance with which could adversely affect the business.
• The company and its affiliated PCs are subject to malpractice and other similar claims, and may be unable to obtain or maintain adequate insurance.
• Events or rumors relating to brand names or inability to defend intellectual property infringement claims could significantly impact the business.
• Failure to comply with applicable federal and state data privacy and security laws could result in civil or criminal sanctions or damage awards, and increased compliance costs.
• Reliance on proprietary and third-party management information systems carries risks of failure, delays, or service interruptions.
• Failure to properly maintain data integrity or strategically implement/upgrade information systems could materially adversely affect reputation and business.
• Security system breaches could lead to civil liability and diminished public perception, negatively affecting the ability to attract and retain patients.
• Inability to effectively control unauthorized actions of third parties who may have access to patient data.
• Risks related to credit card and debit card payments, including increased fees, billing software malfunctions, and PCI DSS compliance issues.
• The restatement of previously issued financial statements may lead to additional risks and uncertainties, including loss of investor confidence and negative impacts on the stock price.
• Short-selling strategies and negative opinions posted on the internet may drive down the market price of common stock and could result in class action lawsuits.
• Future sales of common stock may depress the stock price due to the large number of shares eligible for future sale or exchange.
• Claims for indemnification by directors and officers may reduce available funds to satisfy successful third-party claims.

Future Outlook

The company anticipates 2025 will continue to be a volatile macroeconomic environment with elevated cost inflation. It expects to drive greater efficiencies across operations, development, and marketing programs, and further leverage technology and existing support infrastructure. The company believes it will be able to control corporate costs over time to enhance margins as general and administrative expenses grow at a slower rate than its clinic base and sales. Long-term capital requirements, primarily for acquisitions and other corporate initiatives, could be dependent on the ability to access additional funds through debt and/or equity markets.

Management Comments

• Our mission is to improve quality of life through routine and affordable chiropractic care.
• We seek to be the leading provider of chiropractic care in the markets we serve and to become the most recognized brand in our industry.
• We will continue the rapid and franchise focused expansion of chiropractic clinics in key markets throughout North America and potentially abroad.
• Our future growth strategy will focus on accelerating the development of our franchise base through the sale of additional franchises and through the continued support of our robust regional developer network.
• We believe that we continue to have a sound business concept and will benefit from the fundamental changes taking place in the manner in which Americans access chiropractic care and their growing interest in seeking effective, affordable natural solutions for general wellness.
• We anticipate that 2025 will continue to be a volatile macroeconomic environment.
• We believe that we have created a robust framework for the refranchising effort, organizing clinics into clusters, and generating comprehensive disclosure packets for marketing efficiency, and that we have received significant interest to date from our existing franchisees.
• We believe that our existing cash and cash equivalents, our anticipated cash flows from operations and amounts available under our line of credit will be sufficient to fund our anticipated operating and investment needs for at least the next 12 months.

Industry Context

The chiropractic industry in the United States is large, estimated at $20.6 billion annually, and highly fragmented, with the top 50 practices accounting for only 4% of total industry revenue. Employment of chiropractors is expected to grow 10% from 2023 to 2033, driven by rising interest in integrative healthcare, an aging population, and the need to replace retiring workers. The company's private pay, non-insurance, cash-based model positions it as an efficient, low-cost, consumer-oriented provider. This approach has enabled it to attract a significant number of new patients, with 36% of new patients in 2024 being first-time chiropractic users, demonstrating its role in expanding the overall market. Most competitors operate under an insurance-based model, making the company's cash-only, appointment-free model a distinct competitive advantage.

Comparison to Industry Standards

• The company's average fee of approximately $36 per adjustment as of December 31, 2024, is about 52% lower than the average industry cost of approximately $76 for comparable procedures offered by traditional chiropractors, according to 2024 industry data from Chiropractic Economics.
• The company attracted an average of 992 new patients per clinic (for clinics open for the full 12 months of 2024), significantly higher than the chiropractic industry average of 468 new patients per year for traditional insurance-based non-multidisciplinary or integrated practices, based on a 2024 Chiropractic Economics survey.
• The company's clinics see an average of 301 patient visits per week (for clinics open for the full 12 months of 2024), compared to the chiropractic industry average of 113 patients per week for non-multidisciplinary or integrated practices, according to the same 2024 Chiropractic Economics survey.
• The company is the largest chiropractic franchisor in the United States, with over 967 clinics operating across 41 states and the District of Columbia, making its brand approximately six times larger than the next largest chiropractic chain as of December 2024.

Management Changes

Corporate Governance

Legal Proceedings

• Accrued $1.5 million in the second quarter of 2024 for settlement agreements from litigation related to employment matters.
• Accrued $3.4 million as of December 31, 2024, for a medical injury claim settlement agreement reached on February 25, 2025, with a $1.9 million receivable from the company's insurance offsetting the expense.
• Faces potential (though diminishing) litigation related to negative allegations posted on an internet platform in 2021, which previously caused a stock price decline.

Related Party Transactions

• Jefferson Gramm, a beneficial holder of over 5% of common stock (approximately 26% as of December 31, 2024) and a director since January 2, 2024, is involved in several transactions.
• Two franchise licenses were sold in December 2020 to Marshall Gramm, a family member of Mr. Jefferson Gramm, for $39,900 and $29,900 (reflecting a multi-unit discount).
• Two franchise licenses were sold in April 2020 and 2021 to a franchisee in which Mr. Jefferson Gramm was a 50% co-partner, for $39,900 and $29,900 respectively. Mr. Gramm divested his interest in these clinics in Q4 2024.
• Mr. Gramm loaned approximately $370,000 to an unaffiliated franchisee in October 2020, with a remaining balance of $270,800 as of December 31, 2024.

Stakeholder Impact

• Shareholders: Significant negative impact on investor confidence and potential adverse effects on stock price due to the restatement and identified material weakness. Potential for stockholder litigation and dilution from future capital raises.
• Employees: Labor shortages may lead to increased wages and benefits, but also potential for reduced discretionary spending affecting demand for services. Cybersecurity incidents could impact employee data.
• Franchisees: Dependence on their operational success for royalty revenue. Potential for increased liability due to evolving 'joint employer' regulations and stricter scrutiny from state chiropractic boards.
• Customers/Patients: Potential impact on service quality if labor shortages persist. Data breaches, such as the November 2022 incident, could diminish public perception of security measures.
• Creditors: The company's debt level and compliance with credit facility covenants are critical, especially given the financial restatement and ongoing net losses.

Next Steps

• Remediate the identified material weakness in internal control over financial reporting.
• Continue to implement the refranchising strategy for company-owned or managed clinics, aiming to finalize LOI term negotiations for the full portfolio.
• Drive greater efficiencies across operations, development, and marketing programs.
• Control corporate costs over time to enhance margins.
• Expand and strengthen relationships with chiropractic colleges to increase the applicant flow of qualified candidates.
• Move to a quarterly security testing regimen in 2025 for cybersecurity programs.
• Complete the ISO 27001 Information Security Management certification project in March 2025.
• Evaluate and quantify other possible sources of taxable income to assess the realization of deferred tax assets.

Key Dates

Recommendation

The restatement of financial statements for a material error, coupled with the identification of a material weakness in internal controls, signals significant governance and operational deficiencies. This is the second restatement in two years, which severely erodes investor confidence and raises concerns about the reliability of financial reporting. The company continues to report net losses, and while system-wide sales show growth, the decline in Adjusted EBITDA from continuing operations and negative comparable sales for mature clinics indicate underlying profitability challenges. The ongoing labor shortages and inflationary pressures further strain the business. The strategic shift to a pure-play franchisor model, while potentially positive long-term, introduces near-term uncertainties and execution risks. Given these compounding issues, particularly the repeated financial reporting failures, a seasoned investor would likely recommend selling to mitigate further risk until the company demonstrates consistent, accurate financial reporting and sustained profitability.

Keywords

Chiropractic, Franchisor, SEC Filing, Restatement, Internal Controls, Material Weakness, Financial Reporting, Asset Valuation, Discontinued Operations, Franchise Sales, Patient Visits, System-wide Sales, Labor Shortage, Inflation, Corporate Governance, Risk Management, JYNT, NASDAQ